Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

ALEC – Alector Inc.

ALEC — Price & Forward EBITDA
Forward EBITDA (M)

Float Short %

8.07

Margin Of Safety %

Put/Call OI Ratio

0.01

EPS Next Q Diff

0.06

EPS Last/This Y

0.26

EPS This/Next Y

0.14

Price

2.01

Target Price

2.88

Analyst Recom

2.88

Performance Q

37.93

Upside

-1,003.5%

Beta

0.59

Ticker: ALEC




20 items of 1

DateSymbolLatestP/C OIP/C VolTotal OI
2026-02-27ALEC2.450.010.016236
2026-03-02ALEC2.20.010.006055
2026-03-03ALEC2.110.010.006015
2026-03-04ALEC2.150.010.266017
2026-03-05ALEC20.010.046013
2026-03-06ALEC2.010.010.016011
2026-03-09ALEC2.180.010.085983
2026-03-10ALEC2.370.010.005992
2026-03-11ALEC2.330.010.006046
2026-03-12ALEC2.230.010.006020
2026-03-13ALEC2.230.010.006020
2026-03-17ALEC2.240.010.035944
2026-03-18ALEC2.060.012.005913
2026-03-19ALEC2.060.011.505913
2026-03-20ALEC2.050.010.055913
2026-03-23ALEC2.050.010.024830
2026-03-24ALEC2.090.010.044828
2026-03-25ALEC2.170.010.004852
2026-03-26ALEC2.120.010.004869
2026-03-27ALEC2.010.015.004850
DateSymbolLatestP/C OIP/C VolTotal OI
20 items Current Page1 of 1




20 items of 1

DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
2026-02-27ALEC2.46-1716.6- -1.43
2026-03-02ALEC2.2031.7- -0.99
2026-03-03ALEC2.1131.7- -0.99
2026-03-04ALEC2.1531.7- -0.99
2026-03-05ALEC2.0031.7- -0.99
2026-03-06ALEC2.0131.7- -0.99
2026-03-09ALEC2.1925.2- -1.13
2026-03-10ALEC2.3725.2- -1.13
2026-03-11ALEC2.3325.2- -1.13
2026-03-12ALEC2.2425.2- -1.13
2026-03-13ALEC2.2125.2- -1.13
2026-03-17ALEC2.2425.2- -1.13
2026-03-18ALEC2.0625.2- -1.13
2026-03-19ALEC2.0625.2- -1.13
2026-03-20ALEC2.0525.2- -1.13
2026-03-23ALEC2.0525.2- -1.13
2026-03-24ALEC2.0925.2- -1.13
2026-03-25ALEC2.1725.2- -1.13
2026-03-26ALEC2.1225.2- -1.13
2026-03-27ALEC2.0125.2- -1.13
DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
20 items Current Page1 of 1




20 items of 1

DateTickerInsider TransactionsInstitutional TransactionsFloat Short
2026-02-27ALEC-0.87-0.608.28
2026-03-02ALEC-0.820.338.19
2026-03-03ALEC-1.150.338.19
2026-03-04ALEC-1.160.338.19
2026-03-05ALEC-0.890.338.19
2026-03-06ALEC-0.890.338.19
2026-03-09ALEC-0.890.328.19
2026-03-10ALEC-0.890.328.19
2026-03-11ALEC-0.890.328.06
2026-03-12ALEC-0.890.328.06
2026-03-13ALEC-0.890.328.06
2026-03-17ALEC-0.890.368.06
2026-03-18ALEC-0.890.368.06
2026-03-19ALEC-0.890.368.06
2026-03-20ALEC-0.890.368.06
2026-03-23ALEC-0.890.368.06
2026-03-24ALEC-0.890.368.06
2026-03-25ALEC-0.890.368.07
2026-03-26ALEC-0.890.368.07
2026-03-27ALEC-0.890.368.07
DateTickerInsider TransactionsInstitutional TransactionsFloat Short
20 items Current Page1 of 1

Last Quarter Act. EPS

-0.34

Avg. EPS Est. Current Quarter

-0.31

Avg. EPS Est. Next Quarter

-0.28

Insider Transactions

-0.89

Institutional Transactions

0.36

Beta

0.59

Average Sales Estimate Current Quarter

11

Average Sales Estimate Next Quarter

11

Fair Value

Quality Score

7

Growth Score

24

Sentiment Score

57

Actual DrawDown %

95.4

Max Drawdown 5-Year %

-97.7

Target Price

2.88

P/E

Forward P/E

PEG

P/S

10.49

P/B

7.2

P/Free Cash Flow

EPS

-1.39

Average EPS Est. Cur. Y​

-1.13

EPS Next Y. (Est.)

-0.99

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-679.16

Relative Volume

0.51

Return on Equity vs Sector %

-493.7

Return on Equity vs Industry %

-477.4

EPS 1 7Days Diff

-0.2

EPS 1 30Days Diff

-0.18

EBIT Estimation

ALEC Healthcare
$2.00
📉
Swing / Pullback
Buy the dip on strong trends
56 /100
WATCH
Trend
6/20
Pullback
16/25
Volume
11/15
Valuation
12/20
TP/AR
4/10
Options
7/10
RSI
44.4
Range 1M
15.8%
🚀
Momentum Growth
Ride accelerating trends
N/A
28 /100
WEAK
Momentum
2/25
Growth
9/30
Estimates
6/20
Inst/Vol
6/15
Options
5/10
EPS Yr
33.5%
EPS NY
4.6%
52W%
45.1%
💎
Long-Term Value
Quality companies, undervalued
N/A
0 /100
WEAK
🟢 BUY +44% upside
Quality
5/30
Valuation
12/30
Growth
11/25
Stability
5/10
LT Trend
1/5
Upside
+44%
Quality
7
Alector, Inc.
Sector: Healthcare
Industry: Biotechnology
Employees: 103
Alector, Inc., a clinical stage biotechnology company, develops therapies to counteract the progression of neurodegeneration in the United States. Its pipeline includes Nivisnebart, an investigational human recombinant monoclonal antibody for treating prevalent neurodegenerative diseases; AL137, an anti-amyloid beta antibody paired in preclinical development for the potential treatment of Alzheimer's disease; and AL050, a GCase enzyme replacement therapy in preclinical development for the potential treatment of Parkinson's disease and Lewy body dementia in patients having GBA1 gene mutations. The company also develops its preclinical and research pipeline comprising AL064, a tau siRNA for Alzheimer's disease and other tauopathies; ADP062-ABC, an alpha-synuclein siRNA for Parkinson's disease; and ADP065-ABC, an NLRP3 siRNA for neurodegenerative conditions. It has a strategic collaboration agreement with GlaxoSmithKline plc for the development and commercialization of progranulin-elevating monoclonal antibodies, including Latozinemab and Nivisnebart. The company was founded in 2013 and is headquartered in South San Francisco, California.
ALEC

Latest News

Caricamento notizie per ALEC
stock quote shares ALEC – Alector Inc. Stock Price stock today
news today ALEC – Alector Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch ALEC – Alector Inc. yahoo finance google finance
stock history ALEC – Alector Inc. invest stock market
stock prices ALEC premarket after hours
ticker ALEC fair value insiders trading